SDC1 and plasma cell myeloma: Xenografts created by the injection of CD19+ CD138- myeloma cell fractions showed partial CD138 re-expression in the primary engrafted tumor, whereas CD138 expression was almost non-existent in circulating B cells, suggesting that CD138 expression is dependent on environmental cues (30, 31).